Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy

Michael J. Jelinek*, Samantha A. Armstrong, Jyoti D. Patel, Deepa S. Subramaniam

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)e597-e600
JournalClinical Lung Cancer
Issue number6
StatePublished - Nov 2019
Externally publishedYes


  • Circulating tumor DNA
  • Clonal evolution
  • EGFR mutation
  • Liquid biopsy
  • Resistance mutations

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this